The present invention provides compounds of Formula (I): ##STR00001## and pharmaceutically acceptable salts, solvates, esters, and tautomers thereof, wherein: Q is selected from the group consisting of: ##STR00002## and L is selected from the group consisting of: ##STR00003## pharmaceutically compositions comprising one or more compounds of formula (I), and methods of using the compounds of formula (I).

 
Web www.patentalert.com

< Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors

< Pyrazine kinase inhibitors

> 1-substituted-3-.beta.-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same

> Processes for regulating blood glucose in a mammal

~ 00614